Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMD10P2, or "proteasome 26S subunit, non-ATPase, 10 pseudogene 2", is a human pseudogene (NCBI Gene ID: 280644; Ensembl: ENSG00000226652)[3][5][1]. It does not encode a functional protein product and is not known to play a direct biological role or serve as a drug target. The name implies it is related by sequence to the functional proteasome subunit PSMD10, but "P2" and the "pseudogene" designation indicate it is a non-functional genetic element[1][3][5]. No alternative names, protein products, drug interactions, nor disease associations have been reported. Additional context: There is frequent confusion between pseudogenes like PSMD10P2 and the active subunits of the proteasome regulatory complex, such as PSMD2 or PSMD10, which are well-studied components involved in protein degradation and have established roles in cancer biology and therapeutic research[2][7]. However, PSMD10P2 itself does not encode such an active subunit[1][3][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, non-ATPase, 10 pseudogene 2 (PSMD10P2).